Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Bruff Jesse Michael

2. Date of Event Requiring Statement (MM/DD/YYYY) 12/1/2019

3. Issuer Name and Ticker or Trading Symbol

VARIAN MEDICAL SYSTEMS INC [VAR]

(Last) (First) (Middle)

3100 HANSEN WAY

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
SVP Finance, CFO /

(Street)

PALO ALTO, CA 94304

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	550	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Non Qualified Stock Option (Right to Buy)	⁽¹⁾	8/17/2024	Common Stock	3750	$99.26	D
Non Qualified Stock Option (Right to Buy)	⁽²⁾	2/8/2025	Common Stock	1035	$112.82	D
Non Qualified Stock Option (Right to Buy)	⁽³⁾	2/14/2026	Common Stock	5716	$131.77	D
Non Qualified Stock Option (Right to Buy)	⁽⁴⁾	8/15/2026	Common Stock	10465	$107.32	D
Restricted Stock Units	⁽⁵⁾	⁽⁵⁾	Common Stock	2329	⁽⁶⁾	D
Restricted Stock Units	⁽⁷⁾	⁽⁷⁾	Common Stock	840	⁽⁶⁾	D
Restricted Stock Units	⁽⁸⁾	⁽⁸⁾	Common Stock	1265	⁽⁶⁾	D
Restricted Stock Units	⁽⁹⁾	⁽⁹⁾	Common Stock	394	⁽⁶⁾	D

Explanation of Responses:
(1)	Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 8/17/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.
(2)	Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on February 8, 2019, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.
(3)	Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on February 14, 2020, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.
(4)	Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 8/15/2020, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.
(5)	The restricted stock units vest in three equal installments on August 10, 2020, August 10, 2021, and August 10, 2022. Vested shares will be delivered to the reporting person on vest date.
(6)	Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
(7)	The restricted stock units vest on the earlier of August 10, 2020, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date.
(8)	The restricted stock units vest in three equal installments on February 15, 2020, February 15, 2021, and February 15, 2022. Vested shares will be delivered to the reporting person on vest date.
(9)	The restricted stock units vest in three equal installments on February 15, 2019, February 15, 2020, and February 15, 2021. Vested shares will be delivered to the reporting person on vest date.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Bruff Jesse Michael 3100 HANSEN WAY PALO ALTO, CA 94304			SVP Finance, CFO